- Record: found
- Abstract: not found
- Article: not found
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Donna K Arnett ,
Roger S Blumenthal ,
Michelle A Albert
1 ,
Andrew B Buroker
2 ,
Zachary D Goldberger
3 ,
Ellen J Hahn
1 ,
Cheryl Dennison Himmelfarb
1 ,
Amit Khera
1 ,
Donald Lloyd-Jones
1 ,
J William McEvoy
1 ,
Erin D Michos
1 ,
Michael D Miedema
1 ,
Daniel Muñoz
1 ,
Sidney C Smith
1 ,
Salim S Virani
1 ,
Kim A Williams
1 ,
Joseph Yeboah
1 ,
Boback Ziaeian
4
September 10 2019
AHA Scientific Statements,
LDL cholesterol,
antihypertensive agents,
aspirin,
atherosclerosis,
atherosclerotic cardiovascular disease,
atrial fibrillation,
behavior modification,
behavior therapy,
blood cholesterol,
blood pressure,
body mass index,
cardiovascular,
cardiovascular disease,
cardiovascular team-based care,
cholesterol,
chronic kidney disease,
coronary artery calcium score,
coronary disease,
coronary heart disease,
cost,
diabetes mellitus,
diet,
dietary fats,
dietary patterns,
dietary sodium,
dyslipidemia,
e-cigarettes,
exercise,
guidelines,
health services accessibility,
healthcare disparities,
heart failure,
hypertension,
lifestyle,
lipids,
measurement,
myocardial infarction,
nicotine,
nonpharmacological treatment,
nutrition,
physical activity,
prejudice,
primary prevention,
psychosocial deprivation,
public health,
quality indicators,
quality measurement,
risk assessment,
risk factors,
risk reduction,
risk reduction discussion,
risk treatment discussion,
risk-enhancing factors,
secondhand smoke,
sleep,
smoking,
smoking cessation,
social determinants of health,
socioeconomic factors,
statin therapy,
systems of care,
tobacco,
tobacco smoke pollution,
treatment adherence,
treatment outcomes,
type 2 diabetes mellitus,
waist circumference,
weight loss
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d4800991e141">Circulation</p>
Related collections
Author and article information
AHA Scientific Statements,LDL cholesterol,antihypertensive agents,aspirin,atherosclerosis,atherosclerotic cardiovascular disease,atrial fibrillation,behavior modification,behavior therapy,blood cholesterol,blood pressure,body mass index,cardiovascular,cardiovascular disease,cardiovascular team-based care,cholesterol,chronic kidney disease,coronary artery calcium score,coronary disease,coronary heart disease,cost,diabetes mellitus,diet,dietary fats,dietary patterns,dietary sodium,dyslipidemia,e-cigarettes,exercise,guidelines,health services accessibility,healthcare disparities,heart failure,hypertension,lifestyle,lipids,measurement,myocardial infarction,nicotine,nonpharmacological treatment,nutrition,physical activity,prejudice,primary prevention,psychosocial deprivation,public health,quality indicators,quality measurement,risk assessment,risk factors,risk reduction,risk reduction discussion,risk treatment discussion,risk-enhancing factors,secondhand smoke,sleep,smoking,smoking cessation,social determinants of health,socioeconomic factors,statin therapy,systems of care,tobacco,tobacco smoke pollution,treatment adherence,treatment outcomes,type 2 diabetes mellitus,waist circumference,weight loss
AHA Scientific Statements, LDL cholesterol, antihypertensive agents, aspirin, atherosclerosis, atherosclerotic cardiovascular disease, atrial fibrillation, behavior modification, behavior therapy, blood cholesterol, blood pressure, body mass index, cardiovascular, cardiovascular disease, cardiovascular team-based care, cholesterol, chronic kidney disease, coronary artery calcium score, coronary disease, coronary heart disease, cost, diabetes mellitus, diet, dietary fats, dietary patterns, dietary sodium, dyslipidemia, e-cigarettes, exercise, guidelines, health services accessibility, healthcare disparities, heart failure, hypertension, lifestyle, lipids, measurement, myocardial infarction, nicotine, nonpharmacological treatment, nutrition, physical activity, prejudice, primary prevention, psychosocial deprivation, public health, quality indicators, quality measurement, risk assessment, risk factors, risk reduction, risk reduction discussion, risk treatment discussion, risk-enhancing factors, secondhand smoke, sleep, smoking, smoking cessation, social determinants of health, socioeconomic factors, statin therapy, systems of care, tobacco, tobacco smoke pollution, treatment adherence, treatment outcomes, type 2 diabetes mellitus, waist circumference, weight loss